News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Contracts would secure haemophilia treatment

11 May 2005

National contracts would secure haemophilia treatment

Government drug funding agency PHARMAC is consulting on national agreements to secure the supply of Recombinant Factor VIII for the next three years.

Used in the treatment of haemophilia, Recombinant Factor VIII provides a life-saving clotting factor for around 200 New Zealanders who receive regular treatment.

The provisional agreements with the three incumbent suppliers would enable patients to continue on their current Recombinant Factor VIII treatment until at least June 2008.

PHARMAC Chief Executive Wayne McNee says the proposals would see patients able to continue their treatment uninterrupted.

"Patients would not notice any change from moving to national contracts and their health needs would still be met," says Wayne McNee.

"Securing the ongoing supply of Recombinant Factor VIII would not only guarantee supply of an essential medical product, it would also provide considerable financial savings to DHBs."

If approved, the proposals with Bayer New Zealand, Baxter Healthcare and Wyeth Pharmaceuticals would ensure all products remain available nationally until at least June 2008 in addition to providing savings to DHBs.

"Any savings could be used for more treatment of haemophilia or in other areas of health."

Consultation is now underway and submissions are being received until 13 May 2005.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland